ArticleJAC-antimicrobial resistance2025
Understanding the implementation of antimicrobial stewardship in Utah community pharmacies.
Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Objectives: Antimicrobial stewardship (AS) is essential to optimize antibiotic use and combat resistance. This study evaluated the implementation of AS activities in community pharmacies across Utah and assessed pharmacists' understanding of AS principles, current practices and barriers. This study also aimed to increase community pharmacists' awareness of preventing drug-resistant infections. Addressing community pharmacies AS barriers can significantly enhance AS efforts, to ensure optimal patient outcomes while combating antibiotic resistance. Methods: A cross-sectional survey was distributed to community pharmacies throughout Utah. The survey collected data on pharmacy demographics, AS knowledge, implementation practices, perceived barriers and potential facilitators related to AS. Results: Out of 110 respondents, 50% worked in privately owned pharmacies, and 78.7% held a Doctorate in Pharmacy. While 71.6% were familiar with ASP, 28.4% were not. Major barriers to implementing AS in community pharmacies included limited access to patient data (79.8%) and the absence of standardized AS guidelines (53%). Pharmacists identified several key facilitators that could support AS implementation, which included access to guidelines (75.2%) and better collaboration with providers (75.2%). Additionally, (86.4%) of pharmacists highlighted improved access to patient records was essential or effective for AS implementation. However, only (47.7%) of pharmacists consistently intervened when an antibiotic dosage or frequency appeared inappropriate, which indicates potential gaps in AS-related interventions. Conclusions: Enhancing pharmacists' access to clinical data and fostering collaboration with healthcare providers are crucial steps towards effective AS implementation in community settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.